Cargando…

Concurrent Chemoradiation for Mediastinal Oligometastases From Cervical Cancer: A Potentially Curative Treatment

Currently, the standard treatment for women with metastatic cervical cancer is palliative chemotherapy with or without bevacizumab. Patients with oligometastatic disease seem to have a better prognosis than those with disseminated disease. We present two cases of women with mediastinal oligometastat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonilla, Carlos E, Zapata Laguado, Martin, Paez Quintero, Heliberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581221/ https://www.ncbi.nlm.nih.gov/pubmed/33110731 http://dx.doi.org/10.7759/cureus.10596

Ejemplares similares

A Retrospective Study of Metastatic Renal Cell Carcinoma Patients With Brain Metastases
por: Zapata Laguado, Martin, et al.
Publicado: (2023)

Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
por: Chhabra, Arpit, et al.
Publicado: (2014)

Early Metastasis of Clear Cell Renal Cell Carcinoma to the Esophagus: A Case Report
por: Paez Quintero, Heliberto, et al.
Publicado: (2023)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
por: Chopra, Supriya, et al.
Publicado: (2022)

Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes
por: Wang, Huan-Huan, et al.
Publicado: (2016)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
por: Warren, Kwanza T., et al.
Publicado: (2019)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Assessment of the Role of Gefitinib With Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
por: Prajapati, Raju, et al.
Publicado: (2022)

Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis
por: Lin, Junzhong, et al.
Publicado: (2017)

Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
por: Tong, Charles C. L., et al.
Publicado: (2012)

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
por: Khurshid, Humera, et al.
Publicado: (2012)

The Incorporation of Immunotherapy and Targeted Therapy Into Chemoradiation for Cervical Cancer: A Focused Review
por: Odiase, Otasowie, et al.
Publicado: (2021)

Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma
por: Nittala, Mary R, et al.
Publicado: (2021)

Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence
por: Dyer, Brandon A, et al.
Publicado: (2017)

Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013)

Tracheal-Mediastinal Fistula Post-chemoradiation Therapy
por: McCarthy, Joseph, et al.
Publicado: (2014)

Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer
por: Haritha, V. S., et al.
Publicado: (2022)

HIV and Early Treatment Outcomes Among Women With Cervical Cancer Treated With Concurrent Chemoradiation in Tanzania
por: Mrema, Alita Steven, et al.
Publicado: (2023)

A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
por: Tangjitgamol, Siriwan, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients
por: Burkon, Petr, et al.
Publicado: (2021)

Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors
por: Ji, Xiaoqin, et al.
Publicado: (2021)

The Efficacy and Safety of Transarterial Chemoembolization Plus Iodine 125 Seed Implantation in the Treatment of Hepatocellular Carcinoma With Oligometastases: A Case Series Reports
por: Zhang, Weihua, et al.
Publicado: (2022)

Advanced gastric cancer with metachronous intracranial oligometastases without recurrence after multidisciplinary team discussion and comprehensive treatment: a case report
por: Shao, Lijuan, et al.
Publicado: (2023)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Oligometastases in prostate cancer: Ablative treatment
por: Palacios-Eito, Amalia, et al.
Publicado: (2019)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
por: Xu, Chenyang, et al.
Publicado: (2022)

Intra-fraction motion of pelvic oligometastases and feasibility of PTV margin reduction using MRI guided adaptive radiotherapy
por: Snyder, Jeffrey, et al.
Publicado: (2023)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy
por: Ming, Cheng, et al.
Publicado: (2023)

Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer
por: Yu, Jeong Il, et al.
Publicado: (2011)

Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
por: Li, Shuai, et al.
Publicado: (2019)

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin
por: Xu, Zhiyuan, et al.
Publicado: (2022)

Analysis of Treatment Outcomes and Prognosis After Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Peng, Qing-he, et al.
Publicado: (2022)

Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting
por: Pereira, Elena, et al.
Publicado: (2016)

Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience
por: Tahover, Esther, et al.
Publicado: (2018)

Neurofibromatosis Type 1 – Association with Breast Cancer, Basal Cell Carcinoma of the Skin, and Low-Grade Peripheral Nerve Sheath Sarcoma: Case Report and Literature Review
por: Zapata Laguado, Martin Ignacio, et al.
Publicado: (2019)

PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer
por: Zhang, Hanqun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n69n9db6e3bi6nuc4bvvs5pdep